EUVIMEDEUVIMED entdecken
Crossref

Zika virus screening during pregnancy: Results and lessons learned from a screening program and a post‐delivery follow‐up analysis (2016–2022)

Andrés Martínez-Arias, Lluís Valerio, Sílvia Roure-Díez, Gema Fernández-Rivas, Belén Rivaya, Maria T Pérez-Olmeda, Laura Soldevila-Langa, Ignasi Parrón, Bonaventura Clotet-Sala, Xavier Vallès, Carlos Rodrigo

Birth Defects Research · 2023

DOI: 10.1002/bdr2.2236 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Birth Defects Research, 2023. Verfasst von Andrés Martínez-Arias und 10 weiteren Autor:innen. Beteiligte Einrichtung: Consorci Corporació Sanitària Parc Taulí, Emergency Service, Universitat Autònoma de Barcelona, Sabadell, Catalonia, Spain. Hauptthemen laut MEDLINE: Zika Virus Infection, Zika Virus, Pregnancy Complications, Infectious. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate a Zika virus screening program applied to asymptomatic exposed pregnant women. Methodology Analysis of data generated during the roll out of a Zika screening program. We included socio‐demographic data, ultrasounds, and serological results (IgM, IgG, and Plaque Reduction Neutralization Test; PRNT) from asymptomatic pregnant women exposed to Zika virus enrolled in the screening program between 2016 to 2019.

Results

We included 406 asymptomatic ZIKV‐exposed pregnant women who gave 400 full‐term new‐borns. The median age was 30 years (IQR = 25–34), which was lower (29 years; IQR = 24–34) among women of non‐EU migrant origin (76.4% of the sample). Migrant women tended to delay the first pre‐natal consultation compared to EU origin women ( p = .003). Overall, 83.2% ( N = 328) of participants had ZIKV low risk serological profile (IgM−/IgG− or IgM−/IgG+ and PRNT‐), 3.0% ( N = 12) showed high risk of recent ZIKV infection (IgM+ or PRNT+) and 13.7% ( N = 54) had indeterminate results. A fetal malformation was identified in 29 children (9.3%). Fetal malformation was associated with a ZIKV high risk serological profile [24 out of the 246 (1.6%) with low risk profile and 3 out of the 12 with at high risk profile (25.0%; p = .02)]. Four newborns with high risk profile had a positive ZIKV‐PCR test, which included two cases with microcephaly. No association was observed between maternal exposure to ZIKV infection and developmental abnormalities during the post‐natal period follow‐up.

Conclusions

The ZIKV‐screening program had considerable costs and yielded a high rate of indeterminate results among asymptomatic pregnant women. Considering the poor value for decision‐making of the results, efforts should focus on providing early access to routine maternity care, especially to migrant women. A simpler screening protocol might consider an initial ZIKV‐PCR or IgM determination and subsequent referral to a fetal medicine specialist in those women with a positive result and/or whom ultrasound examination has revealed fetal abnormalities (10% of total women in our study sample).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Zika Virus InfectionZika VirusPregnancy Complications, InfectiousHumansFemalePregnancyAdultMass ScreeningFollow-Up StudiesYoung AdultImmunoglobulin MAntibodies, Viral

Stichwörter der Autor:innen

Zikaflaviviruspregnancyscreeningvertical transmission

Substanzen

Immunoglobulin MAntibodies, Viral

Autor:innen und Institutionen

  • Consorci Corporació Sanitària Parc Taulí, Emergency Service, Universitat Autònoma de Barcelona, Sabadell, Catalonia, Spain.
  • Programa de Salut Internacional (PROSICS), Gerència Territorial Metropolitana nord, Institut Català de la Salut.
  • Infectious Diseases Service, Hospital Universitari Germans Trias i Pujol, Institut Català de la Salut, Universitat Autònoma de Barcelona, Badalona, Catalonia, Spain.
  • Microbiology Service, Hospital Universitari Germans Trias i Pujol, Institut Català de la Salut, Universitat Autònoma de Barcelona, Badalona, Catalonia, Spain.
  • Centro Nacional de Microbiología, Unidad de Serología, Instituto de Salud Carlos III, Madrid, Spain.
  • Barcelonès nord-Maresme Epidemiologic Surveillance and Emergency Response Service, Health Department, Generalitat de Catalunya, Barcelona, Spain.

Zitieren

APA

Martínez-Arias, A., Valerio, L., Roure-Díez, S., Fernández-Rivas, G., Rivaya, B., Pérez-Olmeda, M. T., Soldevila-Langa, L., Parrón, I., Clotet-Sala, B., Vallès, X., & Rodrigo, C. (2023). Zika virus screening during pregnancy: Results and lessons learned from a screening program and a post‐delivery follow‐up analysis (2016–2022). Birth Defects Research. https://doi.org/10.1002/bdr2.2236

Vancouver

Martínez-Arias A, Valerio L, Roure-Díez S, Fernández-Rivas G, Rivaya B, Pérez-Olmeda MT, et al. Zika virus screening during pregnancy: Results and lessons learned from a screening program and a post‐delivery follow‐up analysis (2016–2022). Birth Defects Research. 2023. doi:10.1002/bdr2.2236

BibTeX
@article{MartnezArias2023,
  author = {Martínez-Arias, Andrés and Valerio, Lluís and Roure-Díez, Sílvia and Fernández-Rivas, Gema and Rivaya, Belén and Pérez-Olmeda, Maria T and Soldevila-Langa, Laura and Parrón, Ignasi and Clotet-Sala, Bonaventura and Vallès, Xavier and Rodrigo, Carlos},
  title = {Zika virus screening during pregnancy: Results and lessons learned from a screening program and a post‐delivery follow‐up analysis (2016–2022)},
  journal = {Birth Defects Research},
  year = {2023},
  doi = {10.1002/bdr2.2236}
}
Kostenlos starten →